Press Releases & Presentations

Press Releases & Presentations

Presentations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired Read more
View HTML
Toggle Summary Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors
Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors TUCSON, Ariz., March 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal Read more
View HTML
Toggle Summary Accelerate Diagnostics goes to NASDAQ
Accelerate Diagnostics to begin trading on NASDAQ under the ticker symbol AXDX on Wednesday, December 26, 2012. Read more
View HTML
Toggle Summary Accelr8 Announces New Management
Larry Mehren joins AXK as CEO and President. Brings track record of success as senior executive in diagnostic industry. Read more
View HTML
Toggle Summary Accelr8 Closes on Investment
Accelr8 closes on previously announced sale of common stock. Read more
View HTML
Toggle Summary Accelr8 Presents Two Studies at ASM 2012 and Receives Acceptance to Present a New Blood Study
Accurate 3-hour results for complex ESBL "superbugs" in blood cultures. 10-minute specimen cleanup for automation eliminates complicated mechanical components. New study accepted for same-day blood cultures. Read more
View HTML
Toggle Summary Accelr8 and Denver Health Notified by Department of Defense for Rapid Diagnostics Award
Accelr8 and Denver Health recommended for $2 million, 35-month project to develop BACcel&#8482 application for wounded warriors and other areas of military medicine. Read more
View HTML
Toggle Summary Accelr8 Attracts Up To $35 Million Private Equity Investment
Private equity firm buys common stock with warrants, brings long track record of success in medical technology business development. Read more
View HTML
Toggle Summary Accelr8 Announces Development Expansion for Blood-Based Diagnostic Tests
Adding BACcel&#8482 test panel for multiple pathogens and multiple drug resistance types for positive blood cultures. Adding BAC-Xtrax&#8482 automated 10-minute specimen preparation, also potential as a stand-alone product. Read more
View HTML
Toggle Summary Accelr8 Announces Interim Plan and Advanced Studies
Transition with collaboration, Proof of Concept begins with complex Gram-negative bacilli in blood culture Read more
View HTML
:

Day High:
Day Low:  
Volume:    

Copyright West LLC. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates